Suppr超能文献

减重手术对脂联素、趋化素、纤溶酶原激活物抑制剂-1、瘦素、抵抗素和内脂素循环水平的影响:系统评价和荟萃分析。

Effect of Bariatric Surgery on the Circulating Level of Adiponectin, Chemerin, Plasminogen Activator Inhibitor-1, Leptin, Resistin, and Visfatin: A Systematic Review and Meta-Analysis.

机构信息

Department of Community Nutrition, Tehran University of Medical Sciences, Tehran, Iran.

Department of Cellular and Molecular Nutrition, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Horm Metab Res. 2020 Apr;52(4):207-215. doi: 10.1055/a-1129-6785. Epub 2020 Apr 8.

Abstract

Different adipokines secreted from adipose tissue, exert a range of physiological effects. The aim of present systematic review and meta-analysis was to critically investigate the consequence of bariatric surgery on circulating adipokines, that is, adiponectin, leptin, visfatin, resistin, plasminogen activator inhibitor, and chemerin. After systematically checking the following electronic databases: ISI web of Science, Scopus and PubMed without limitation in time and language up to February 2019, a pool based on a random effect model was established. Eighty-five eligible studies were entered for quantitative analysis. Our meta-analysis revealed that circulating adiponectin increased significantly after bariatric surgery [Standardized mean difference (SMD)=1.401, 95% CI: 1.101, 1.701, p<0.001]; whilst leptin (SMD=-2.178, 95% CI: -2.433, -1.923, p<0.001), PAI-1 (-14.928 ng/ml 95% CI: -21.794, -8.063, p<0.001), and chemerin (-50.238 ng/ml 95% CI: -85.708, -14.768, p<0.001) decreased. However, serum visfatin (2.05 ng/ml, 95% CI: -5.07, 9.17, p=0.573) and resistin (-2.080 ng/ml, 95% CI: -5.352, 1.192, p=0.21) were unchanged. In conclusion, bariatric surgery is associated with a reduction in specific adipokines including leptin, chemerin, and PAI-1, whereas adiponectin is raised, adaptations that could be indicative of improved fat mass and function.

摘要

不同的脂肪组织分泌的脂肪因子,发挥着广泛的生理作用。本系统评价和荟萃分析的目的是批判性地研究减重手术对循环脂肪因子(即脂联素、瘦素、内脂素、抵抗素、纤溶酶原激活物抑制剂和趋化素)的影响。在系统地检查了以下电子数据库:ISI web of Science、Scopus 和 PubMed 之后,我们没有时间和语言限制,检索截至 2019 年 2 月,建立了一个基于随机效应模型的汇总。85 项符合条件的研究纳入定量分析。我们的荟萃分析显示,减重手术后循环脂联素显著增加[标准化均数差(SMD)=1.401,95%置信区间(CI):1.101,1.701,p<0.001];而瘦素(SMD=-2.178,95%CI:-2.433,-1.923,p<0.001)、纤溶酶原激活物抑制剂(-14.928ng/ml 95%CI:-21.794,-8.063,p<0.001)和趋化素(-50.238ng/ml 95%CI:-85.708,-14.768,p<0.001)下降。然而,血清内脂素(2.05ng/ml,95%CI:-5.07,9.17,p=0.573)和抵抗素(-2.080ng/ml,95%CI:-5.352,1.192,p=0.21)无变化。总之,减重手术与特定脂肪因子的减少有关,包括瘦素、趋化素和纤溶酶原激活物抑制剂,而脂联素升高,这些适应性可能表明脂肪质量和功能得到改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验